In cases of emerging viral pathogens such as Monkeypox Virus, when there is no test that can be conducted to validate the efficacy of a disinfectant, the US Environmental Protection Agency utilizes their Emerging Viral Pathogens Policy to determine the expected efficacy of a disinfectant against an emerging virus. In the case of an enveloped virus such as Monkeypox Virus, the following criteria are used to determine efficacy of a disinfectant upon enactment of the Emerging Viral Pathogens Policy:
To view the full Press Release [PDF], see below:
Peroxigard-EVP-Letter-for-Monkeypox-Virus